December ICE NY cocoa (CCZ24) today is down -321 (-4.43%), and December ICE London cocoa #7 (CAZ24) is down -176 (-3.10%). Cocoa prices today are sharply lower and posted 1-week lows. Today's rally in the dollar index (DXY00) to a 4-month high weighed on most commodity prices, including cocoa. Cocoa prices were already on the defensive due to the acceleration of the Ivory Coast cocoa harvest. Mond...
December ICE NY cocoa (CCZ24) today is down -321 (-4.43%), and December ICE London cocoa #7 (CAZ24) is down -176 (-3.10%). Cocoa prices today are sharply lower and posted 1-week lows. Today's rally in the dollar index (DXY00) to a 4-month high weighed on most commodity prices, including cocoa. Cocoa prices were already on the defensive due to the acceleration of the Ivory Coast cocoa harvest. Monday's government data showed that Ivory Coast farmers shipped 365,072 MT of cocoa to ports from October 1 to November 3, up +26% from 288,686 MT shipped the same time last year. The Ivory Coast is the world's largest cocoa producer. Cocoa prices were also undercut when the Ivory Coast regulator Le Conseil Cafe-Cacao on October 18 raised its Ivory Coast 2024/25 cocoa production estimate to a range of 2.1-2.2 MMT from a June forecast of 2.0 MMT. Recent global cocoa demand news was mixed. The National Confectioners Association on October 17 reported that North American Q3 cocoa grindings rose +12% y/y to 109,264 MT. Also, the Cocoa Association of Asia reported that Q3 Asian cocoa grinding rose +2.6% y/y to 216,998 MT. However, the European Cocoa Association reported that European Q3 cocoa grindings fell -3.3% y/y to 354,335 MT. Shrinking global cocoa stockpiles are bullish for prices. ICE-monitored cocoa inventories held in US ports have been trending lower for the past 17 months and fell to a 19-year low Tuesday of 1,737,858 bags. Cocoa found support after Ghana's Cocoa Board (Cocobod) on August 20 cut its 2024/25 Ghana cocoa production estimate to 650,000 MT from a June forecast of 700,000 MT. Due to bad weather and crop disease, Ghana's 2023/24 coca harvest sank to a 23-year low of 425,000 MT. Ghana is the world's second-biggest cocoa producer, and its 2024/25 cocoa harvest begins in October. An increase in cocoa production by Cameroon, the world's fifth-largest cocoa producer, is bearish for cocoa prices. On August 21, Cameroon's National Cocoa and Coffee Board reported tha...
OpenAI ( OPENAI ) CEO Sam Altman said Thursday that the U.S. government should be more powerful than the private sector. “The government is supposed to be more powerful than private companies,” Altman said during the Morgan Stanley Technology, Media & Telecom Conference, according to CNBC . Altman also said he thought it was "bad for society" if companies ignored the democratic process because som...
OpenAI ( OPENAI ) CEO Sam Altman said Thursday that the U.S. government should be more powerful than the private sector. “The government is supposed to be more powerful than private companies,” Altman said during the Morgan Stanley Technology, Media & Telecom Conference, according to CNBC . Altman also said he thought it was "bad for society" if companies ignored the democratic process because some people didn't like "the person or people currently in charge." Altman's remarks come in the wake of the U.S. government's decision to “blacklist” rival Anthropic ( ANTHRO ) after it declined to allow the Pentagon to use its AI technology for classified systems unless it received assurances it wouldn't be used for mass domestic surveillance or fully automated weapons. In response, the Trump administration ordered government agencies last Friday to stop using Anthropic's technology and government contractors to stop doing business with the company, declaring it a "supply chain risk." CNBC noted that OpenAI announced an agreement to let the Pentagon use its AI technology for classified systems hours after Anthropic's blacklisting was announced. OpenAI, which was co-founded by Tesla ( TSLA ) and xAI ( X.AI ) CEO Elon Musk, counts Microsoft ( MSFT ) as a major investor. The company is best known for its ChatGPT AI models. More on OpenAI, Anthropic Why Anthropic's Claude Isn't The Cyber-Killer Wall Street Fears Wall Street Lunch: ChatGPT Tops 800M Weekly Active Users Microsoft: An OpenAI Problem (Rating Upgrade) Anthropic formally notified it is a supply chain risk: report OpenAI shifts away from allowing e-commerce directly in ChatGPT: report
Michael Vi/iStock Editorial via Getty Images Roche ( RHHBY ) ( RHHBF ) unit Genentech announced on Thursday that its experimental obesity therapy, petrelintide, developed with Zealand Pharma ( ZLDPF ), succeeded in a mid-stage trial, causing up to 11% weight loss over 42 weeks on average. Citing topline data from its Phase 2 ZUPREME-1 study, the company stated that the amylin analog hit the trial’...
Michael Vi/iStock Editorial via Getty Images Roche ( RHHBY ) ( RHHBF ) unit Genentech announced on Thursday that its experimental obesity therapy, petrelintide, developed with Zealand Pharma ( ZLDPF ), succeeded in a mid-stage trial, causing up to 11% weight loss over 42 weeks on average. Citing topline data from its Phase 2 ZUPREME-1 study, the company stated that the amylin analog hit the trial’s primary endpoint, causing weight loss with a statistically significant and clinically meaningful effect over 28 weeks across all five dosing arms. Genentech added that patients on ZUPREME-1 maintained weight loss effects in response to the once-weekly injectable, reporting an average weight loss of up to 10.7% over 42 weeks, compared to 1.7% on placebo. As for tolerability, the company said that gastrointestinal-related adverse events were the most frequent AEs, and rates of diarrhea and constipation stood in the single-digit range, consistent between on-drug and off-drug arms. Overall, 8.4% of patients who received petrelintide discontinued the study compared to 13.6% of those on placebo. The company expects that final results from ZUPREME-1, which it plans to present at a future medical event, will help it design Phase 3 trials for the candidate. More on Roche Holding, Zealand Pharma Zealand Pharma A/S 2025 Q4 - Results - Earnings Call Presentation Zealand Pharma A/S (ZLDPF) Q4 2025 Earnings Call Transcript Roche Holding AG (RHHBY) Shareholder/Analyst Presentation Roche CEO Schinecker wants a bite of the weight loss drugs market ClearBridge International Growth ACWI Ex-US Strategy adds and exits multiple positions
“Too small for the risk”: The plan to have the U.S. government provide an insurance solution for ships trapped in the Persian Gulf may be impractical, analysts said.
“Too small for the risk”: The plan to have the U.S. government provide an insurance solution for ships trapped in the Persian Gulf may be impractical, analysts said.
imaginima/E+ via Getty Images Seeking Alpha's Quant Rating keeps the Energy Select Sector SPDR ETF ( XLE ) at a solid Buy (4.35 score) despite crude's blistering 20% rally, signaling it's not too late to load up on XLE. Crude oil prices extended their war-fueled rally on Thursday, up nearly 20% overall, as the U.S.-Israel-Iran conflict hit day six, with Strait of Hormuz shipping nearly halted and ...
imaginima/E+ via Getty Images Seeking Alpha's Quant Rating keeps the Energy Select Sector SPDR ETF ( XLE ) at a solid Buy (4.35 score) despite crude's blistering 20% rally, signaling it's not too late to load up on XLE. Crude oil prices extended their war-fueled rally on Thursday, up nearly 20% overall, as the U.S.-Israel-Iran conflict hit day six, with Strait of Hormuz shipping nearly halted and trapping about 20% of global daily oil flows amid tanker attacks and Iranian drone strikes on Gulf infrastructure. The ETF's robust score on valuation, profitability, growth, and momentum holds firm despite the run-up, backed by strong holdings like ExxonMobil and Chevron's dividends. Amid the rally, it is also notable that not a single Quant-rated energy or commodity-energy ETF has dipped into oversold territory with an RSI below 30, signaling sustained bullish momentum rather than exhaustion. XLE's appeal lies in its diversification across majors and midstream, offering a hedge against prolonged volatility. With global LNG expansion and domestic energy security themes intact, energy remains a sector rotation favorite. ETFs: ( USO ), ( BNO ), ( UCO ), ( SCO ), ( USL ), ( DBO ), ( DRIP ), ( GUSH ), ( USOI ), ( UNG ), ( BOIL ), ( KOLD ), ( UNL ), ( FCG ), ( XLE ) More on energy stocks Wall Street Lunch: Hormuz Worries Fuel Oil Prices A Strait Problem For China: How The Iran War Could Squeeze Oil Supply March Madness In Markets: Crude Oil, Chip Stocks, And Critical Data In The Spotlight UBS AG ETRACS Crude Oil Shares Covered Call ETNs due April 24, 2037 declares $1.292 dividend Oil prices surge on worries of prolonged supply disruptions from Middle East war
Maple Leaf Foods press release ( MLFNF ): Q4 Non-GAAP EPS of $0.32. Revenue of $991M (+8.1% Y/Y) beats by $269.36M . More on Maple Leaf Foods Maple Leaf Foods Inc. 2025 Q4 - Results - Earnings Call Presentation Maple Leaf Foods: The Spin-Off That Turns Pork Into A Cash Cow Maple Leaf Foods issues 2026 guidance, raises dividend 10% Seeking Alpha’s Quant Rating on Maple Leaf Foods Historical earning...
Maple Leaf Foods press release ( MLFNF ): Q4 Non-GAAP EPS of $0.32. Revenue of $991M (+8.1% Y/Y) beats by $269.36M . More on Maple Leaf Foods Maple Leaf Foods Inc. 2025 Q4 - Results - Earnings Call Presentation Maple Leaf Foods: The Spin-Off That Turns Pork Into A Cash Cow Maple Leaf Foods issues 2026 guidance, raises dividend 10% Seeking Alpha’s Quant Rating on Maple Leaf Foods Historical earnings data for Maple Leaf Foods
Alexander Sikov The U.S. officials have prepared draft regulations that would restrict AI chip sales globally without U.S. approval, Bloomberg News reported. The proposed rules would require companies to get U.S. permission for virtually all exports of AI accelerators developed by the likes of Nvidia ( NVDA ) and Advanced Micro Devices ( AMD ), a global expansion of restrictions that currently cov...
Alexander Sikov The U.S. officials have prepared draft regulations that would restrict AI chip sales globally without U.S. approval, Bloomberg News reported. The proposed rules would require companies to get U.S. permission for virtually all exports of AI accelerators developed by the likes of Nvidia ( NVDA ) and Advanced Micro Devices ( AMD ), a global expansion of restrictions that currently cover about 40 countries, the report added , citing people with knowledge of the matter. The Commerce Department, the Bureau of Industry and Security, Nvidia, and AMD did not immediately respond to a request for comment from Seeking Alpha. These chips are desired by companies globally for use in data centers that power AI services like OpenAI's ( OPENAI ) ChatGPT and Google's ( GOOG ) ( GOOGL ) Gemini. U.S. President Donald Trump’s team has said repeatedly that they want the world to use U.S. AI, and the draft rules are not meant to function as an Nvidia export ban. Rather, the rules would set up the U.S. government as gatekeeper for the AI industry. Companies and, in some cases, their governments would have to get the U.S. Commerce Department's approval to buy the chips, the report noted. How Trump’s team determines to give these licenses would then decide if countries will be able to establish critical digital infrastructure, technology that many see as key to economic growth, corporate competitiveness, and military sovereignty, according to the report. The specific approval process would depend on how much computing power a company requires. Shipments of up to 1,000 of Nvidia’s latest GB300 graphics processing units, or GPUs, would see a largely simple review with certain exemption opportunities, the report noted. Companies setting up larger clusters would require preclearance before seeking export licenses. These companies could face conditions like disclosing their business models or allowing the U.S. government to visit sites, depending on the specifics of the data cente...
White House Crypto Advisor Counters Jamie Dimon's Stablecoin Yield Logic Authored by Danny Park via The Block , Patrick Witt, the executive director of the President’s Council of Advisors for Digital Assets, made a statement in response to JPMorgan CEO Jamie Dimon's recent comment on stablecoin yields. Earlier this week, Dimon said in an interview with CNBC that platforms that pay yield on stablec...
White House Crypto Advisor Counters Jamie Dimon's Stablecoin Yield Logic Authored by Danny Park via The Block , Patrick Witt, the executive director of the President’s Council of Advisors for Digital Assets, made a statement in response to JPMorgan CEO Jamie Dimon's recent comment on stablecoin yields. Earlier this week, Dimon said in an interview with CNBC that platforms that pay yield on stablecoins should be regulated like banks , arguing that "holding balances and paying interest" constitutes a banking institution. Dimon highlighted the need for a level playing field, suggesting that banks face stringent requirements, including FDIC insurance, anti-money laundering rules, and capital standards, and that stablecoin issuers offering similar interest-like rewards should face a similar level of oversight. In response, Witt wrote on X that Dimon's view misrepresents the issue, claiming that the CEO's argument is deliberately inaccurate. "The deceit here is that it is not the paying of yield on a balance per se that necessitates bank-like regulations, but rather the lending out or rehypothecation of the dollars that make up the underlying balance," Witt said. "The GENIUS Act explicitly forbids stablecoin issuers from doing the latter." Witt added that stablecoin balances should not be viewed as equivalent to bank deposits. The deceit here is that it is not the paying of yield on a balance per se that necessitates bank-like regulations, but rather the lending out or rehypothecation of the dollars that make up the underlying balance. The GENIUS Act explicitly forbids stablecoin issuers from doing the… https://t.co/il0dihdbwM — Patrick Witt (@patrickjwitt) March 4, 2026 This issue was central to the delay in passing broader crypto market structure legislation, such as the CLARITY Act, where negotiations between banks and crypto firms over stablecoin rewards have remained contentious even after the GENIUS Act established a federal framework for payment stablecoins in July...
In the news release, Blue Cycle LLC Joins the Microsoft Intelligent Security Association, issued March 2, 2026 by Blue Cycle LLC over PR Newswire, we are advised by a representative of the company that an additional paragraph has been added. The complete, corrected release follows: Blue Cycle LLC Joins the Microsoft Intelligent Security Association ROCHESTER, N.Y., March 2, 2026 /PRNewswire/ -- Bl...
In the news release, Blue Cycle LLC Joins the Microsoft Intelligent Security Association, issued March 2, 2026 by Blue Cycle LLC over PR Newswire, we are advised by a representative of the company that an additional paragraph has been added. The complete, corrected release follows: Blue Cycle LLC Joins the Microsoft Intelligent Security Association ROCHESTER, N.Y., March 2, 2026 /PRNewswire/ -- Blue Cycle LLC, today announced it has become a member of the Microsoft Intelligent Security Association (MISA), an ecosystem of software development companies and security services partners that have integrated their solutions with Microsoft Security technology to better defend our mutual customers against a world of increasing cyber threats. Blue Cycle LLC (Blue Cycle) is a Cybersecurity Advisory, Services, and Systems Integrator firm operating at the intersection of Microsoft Security, and real-world business complexity. From advanced Microsoft Sentinel deployments to security-first Copilot and AI readiness to agentic development, we help organizations adopt Microsoft Security the right way — not just the fast way. JP Bourget, CEO of Blue Cycle, says: "Joining MISA puts us in a group of Microsoft security partners — and that's exactly where we want to be. It reflects the work we've put into delivering sharp advisory, strong security technologies, and real integration between third-party products and the Microsoft Security ecosystem. At the end of the day, we're here to solve the actual business problem, not just check a compliance box." "The Microsoft Intelligent Security Association has grown into a vibrant ecosystem comprised of the most reliable and trusted security vendors across the globe," said Maria Thomson, Director, Microsoft Intelligent Security Association. "Our members, like Blue Cycle LLC, share Microsoft's commitment to collaboration within the cybersecurity community to improve our customers' ability to predict, detect, and respond to security threats faster...
Micron (MU) has been one of the strongest performers over the past year, reflecting the surge in artificial intelligence (AI) infrastructure spending and the company’s strategic position in the memory industry. Shares are up around 35% year-to-date (YTD) and have surged by more than 307% in 12 months. Notably, AI workloads require enormous amounts of high-bandwidth, high-capacity memory. This has ...
Micron (MU) has been one of the strongest performers over the past year, reflecting the surge in artificial intelligence (AI) infrastructure spending and the company’s strategic position in the memory industry. Shares are up around 35% year-to-date (YTD) and have surged by more than 307% in 12 months. Notably, AI workloads require enormous amounts of high-bandwidth, high-capacity memory. This has created a surge in demand for DRAM and advanced memory solutions, areas where Micron has a strong technological footprint, positioning it well to benefit from this investment cycle. Further, Micron is also benefiting from a widening set of applications for its memory products. Industrial demand is strengthening as autonomous systems are increasingly adopted across sectors. Memory and storage components are increasingly embedded in factory automation systems, video surveillance platforms, aerospace and defense technologies, robotics, and edge networking equipment. These structural shifts are steadily expanding the total addressable market for memory chips, strengthening long-term demand for Micron’s product portfolio. Supply dynamics within the global memory market are also playing in Micron’s favor. The global memory market has historically been cyclical, often swinging between periods of oversupply and sharp price downturns. In the current cycle, however, supply growth has remained constrained while demand has accelerated sharply. The resulting tighter supply conditions have supported stronger pricing across the memory industry, which, in turn, has helped improve Micron's profitability. What’s Next for Micron Stock? Demand for AI infrastructure will remain the major growth driver for Micron in the coming quarters. Hyperscalers are significantly increasing capital expenditure on data centers, which should boost demand for memory and storage products. At the same time, broader adoption of Micron’s products across multiple industries and a constrained supply environment are l...
Micron (MU) has been one of the strongest performers over the past year, reflecting the surge in artificial intelligence (AI) infrastructure spending and the company’s strategic position in the memory industry. Shares are up around 35% year-to-date (YTD) and have surged by more than 307% in 12 months. Notably, AI workloads require enormous amounts of high-bandwidth, high-capacity memory. This has ...
Micron (MU) has been one of the strongest performers over the past year, reflecting the surge in artificial intelligence (AI) infrastructure spending and the company’s strategic position in the memory industry. Shares are up around 35% year-to-date (YTD) and have surged by more than 307% in 12 months. Notably, AI workloads require enormous amounts of high-bandwidth, high-capacity memory. This has created a surge in demand for DRAM and advanced memory solutions, areas where Micron has a strong technological footprint, positioning it well to benefit from this investment cycle. Further, Micron is also benefiting from a widening set of applications for its memory products. Industrial demand is strengthening as autonomous systems are increasingly adopted across sectors. Memory and storage components are increasingly embedded in factory automation systems, video surveillance platforms, aerospace and defense technologies, robotics, and edge networking equipment. These structural shifts are steadily expanding the total addressable market for memory chips, strengthening long-term demand for Micron’s product portfolio. Supply dynamics within the global memory market are also playing in Micron’s favor. The global memory market has historically been cyclical, often swinging between periods of oversupply and sharp price downturns. In the current cycle, however, supply growth has remained constrained while demand has accelerated sharply. The resulting tighter supply conditions have supported stronger pricing across the memory industry, which, in turn, has helped improve Micron's profitability. What’s Next for Micron Stock? Demand for AI infrastructure will remain the major growth driver for Micron in the coming quarters. Hyperscalers are significantly increasing capital expenditure on data centers, which should boost demand for memory and storage products. At the same time, broader adoption of Micron’s products across multiple industries and a constrained supply environment are l...
Micron (MU) has been one of the strongest performers over the past year, reflecting the surge in artificial intelligence (AI) infrastructure spending and the company’s strategic position in the memory industry. Shares are up around 35% year-to-date (YTD) and have surged by more than 307% in 12 months. Notably, AI workloads require enormous amounts of high-bandwidth, high-capacity memory. This has ...
Micron (MU) has been one of the strongest performers over the past year, reflecting the surge in artificial intelligence (AI) infrastructure spending and the company’s strategic position in the memory industry. Shares are up around 35% year-to-date (YTD) and have surged by more than 307% in 12 months. Notably, AI workloads require enormous amounts of high-bandwidth, high-capacity memory. This has created a surge in demand for DRAM and advanced memory solutions, areas where Micron has a strong technological footprint, positioning it well to benefit from this investment cycle. More News from Barchart Further, Micron is also benefiting from a widening set of applications for its memory products. Industrial demand is strengthening as autonomous systems are increasingly adopted across sectors. Memory and storage components are increasingly embedded in factory automation systems, video surveillance platforms, aerospace and defense technologies, robotics, and edge networking equipment. These structural shifts are steadily expanding the total addressable market for memory chips, strengthening long-term demand for Micron’s product portfolio. www.barchart.com Supply dynamics within the global memory market are also playing in Micron’s favor. The global memory market has historically been cyclical, often swinging between periods of oversupply and sharp price downturns. In the current cycle, however, supply growth has remained constrained while demand has accelerated sharply. The resulting tighter supply conditions have supported stronger pricing across the memory industry, which, in turn, has helped improve Micron's profitability. What’s Next for Micron Stock? Demand for AI infrastructure will remain the major growth driver for Micron in the coming quarters. Hyperscalers are significantly increasing capital expenditure on data centers, which should boost demand for memory and storage products. At the same time, broader adoption of Micron’s products across multiple industries a...
Piaggio & C. SpA press release ( PIAGF ): FY 2025 Revenue of €1.5B (-11.8% Y/Y). Net profit of €34M, a reduction of 49.4% from €67.2M on 31 December 2024. More on Piaggio & C. SpA Piaggio & C. SpA (PGGCY) Q4 2025 Earnings Call Transcript Piaggio & C. SpA 2025 Q4 - Results - Earnings Call Presentation Seeking Alpha’s Quant Rating on Piaggio & C. SpA Historical earnings data for Piaggio & C. SpA Div...
Piaggio & C. SpA press release ( PIAGF ): FY 2025 Revenue of €1.5B (-11.8% Y/Y). Net profit of €34M, a reduction of 49.4% from €67.2M on 31 December 2024. More on Piaggio & C. SpA Piaggio & C. SpA (PGGCY) Q4 2025 Earnings Call Transcript Piaggio & C. SpA 2025 Q4 - Results - Earnings Call Presentation Seeking Alpha’s Quant Rating on Piaggio & C. SpA Historical earnings data for Piaggio & C. SpA Dividend scorecard for Piaggio & C. SpA
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Akeso (SEHK:9926) reported long term survival data from a Phase II study of cadonilimab in advanced cervical cancer, highlighting durable benefits in a setting with limited treatment options. The company also entered a global cl...
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Akeso (SEHK:9926) reported long term survival data from a Phase II study of cadonilimab in advanced cervical cancer, highlighting durable benefits in a setting with limited treatment options. The company also entered a global clinical collaboration with INOVIO and major cancer centers to test cadonilimab combination therapy in glioblastoma. Akeso shares last closed at HK$102.0, with the stock up 41.9% over the past year and 156.9% over three years, while return year to date is a 10.0% decline. In that context, the latest data readout and the new collaboration help frame how the market may be weighing both the risks and the potential of cadonilimab within the company’s broader pipeline. For investors, the key questions now are how these cervical cancer and glioblastoma programs might shape Akeso’s future portfolio mix and its ability to reach more global markets. The new trial and the long term survival analysis provide additional clinical datapoints to watch, particularly as regulators and partners assess cadonilimab’s role in combination immunotherapy across hard to treat cancers. Stay updated on the most important news stories for Akeso by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Akeso. SEHK:9926 Earnings & Revenue Growth as at Mar 2026 We've flagged 0 risks for Akeso. See which could impact your investment. For Akeso, this update is really about deepening the case for cadonilimab as a core asset while widening its footprint beyond China. The long term cervical cancer data reinforces that the drug is not only active but can be linked to durable disease control in a hard to treat, late line setting. That supports its positioning against global immunotherapy players such as Merck’s Keytruda, Bristol Myers Squibb’s Opdivo, and ot...